XTLB (XTL Biopharmaceuticals) Forvard P/E multiplikatori
XTL Biopharmaceuticals (XTLB) aksiyalari narxining harakati lupusga qarshi dori sinovlari natijalari va investorlar qidiruviga bog'liq. Kompaniyaning kutilayotgan P/E koeffitsiyenti ushbu kutishlarni vizuallashtiradi, bunda 0.00 qiymati joriy raqamni ko'rsatadi. Foyda o'sishi potentsiali terapiyaning muvaffaqiyatiga qarab kelgusidagi narx belgilash imkoniyatlari bilan bog'liq, laboratoriya jarayonlarini autsorsing qilish orqali esa minimal ekologik ta'sir saqlanmoqda.
XTL Biopharmaceuticals kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati XTL Biopharmaceuticals|XTLB - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar XTL Biopharmaceuticals Ltd|XTLB - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari XTL Biopharmaceuticals|Tezkor likvidlik ko‘rsatkichi xtlbio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
XTLB - Soliqlar to‘langandan keyingi foyda|Kutilayotgan foyda XTL Biopharmaceuticals|XTLB - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati XTL Biopharmaceuticals, Ltd.|XTLB - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori XTL Biopharmaceuticals Ltd|XTLB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) XTL Biopharmaceuticals|XTLB - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi xtlbio.com|XTLB - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi XTL Biopharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:XTL Biopharmaceuticals Ltd.
Forward P/E ko'rsatkichi aksiyaning bozor qiymatini kutilayotgan sof foydaga nisbatan belgilaydi, bu esa investorga kelajakdagi biznes o'sish sur'atlari uchun to'langan premiumning miqdorini baholash imkonini beradi. XTL Biopharmaceuticals (XTLB) kompaniyasining baholashini forward P/E asosida tahlil qilganda, XTL Biopharmaceuticals (XTLB) patentlarining autoimmun kasalliklar dori vositalari uchun litsenziyalashidan tushadigan barqaror royalti to'lovlari foyda tebranishlarini kamaytirishi va ushbu ko'paytiruvchini fundamental tahlil uchun yanada bashorat qilinadigan vositaga aylantirishi ta'kidlanishi lozim.
XTL Biopharmaceuticals (XTLB) raqobatchilari
Prognoz qilingan narxning foydaga nisbati ARGX (argenx)|BNTX (BioNTech Inc.) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (abivax.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati ADMA Corp (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|immunovant.com (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols SA|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori Celldex Corp|Kelajakdagi narxning foydaga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS: Prognoz qilingan narxning foydaga nisbati|ABCL (AbCellera Biologics) - Narxning kelajakdagi foydaga nisbati|TRML (Tourmaline Bio, Inc.) - Prognoz qilingan narxning foydaga nisbati|PGEN: Kapitalizatsiyaning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Pharming Group|Kelajakdagi narxning foydaga nisbati NKTR|Prognoz qilingan narxning foydaga nisbati UPB (Upstream Bio Corp)|ZBIO (Zenas Corp) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori IMNM (Immunome, Inc.)|gossamerbio.com - Kelajakdagi narxning foydaga nisbati|KalVista Pharmaceuticals, Inc. - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Savara Pharma (SVRA)|Kelajakdagi narxning foydaga nisbati Rigel Pharmaceuticals|anaptysbio.com - Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori ATXS|ENGN (enGene Holdings Inc) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori RAPT (RAPT Therapeutics, Inc.)|Forvard P/E multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori KYTX (kyvernatx.com)|Tiziana Life Sciences Ltd (TLSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Theratechnologies, Inc|Forvard P/E multiplikatori AVTX|Prognoz qilingan narxning foydaga nisbati eledon.com ELDN|Forvard P/E multiplikatori AGEN (Agenus Inc.)|Climb Bio Inc. (CLYM) - Prognoz qilingan narx-foyda nisbati|ZURA: Prognoz qilingan narxning foydaga nisbati|ATYR - Forvard P/E multiplikatori|ADAG (adagene.com) - Prognoz qilingan narxning foydaga nisbati|IMA: Kapitalizatsiyaning kelajakdagi foydaga nisbati|STTK (Shattuck Labs Inc) - Forvard P/E multiplikatori|Equillium Bio (EQ) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori CNTB|Prognoz qilingan narxning foydaga nisbati immunic-therapeutics.com IMUX|Forvard P/E multiplikatori ATRA (Atara Bio)|Forvard P/E multiplikatori InflaRx NV IFRX|XFOR - Kelajakdagi narxning foydaga nisbati|ACET: Kelajakdagi narxning foydaga nisbati|celularity.com (CELU) - Kelajakdagi narxning foydaga nisbati|INMB - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati BRNS|Narxning kelajakdagi foydaga nisbati KZR (kezarlifesciences.com)|Prognoz qilingan narxning foydaga nisbati SABS (SAB Biotherapeutics, Inc.)|Kapitalizatsiyaning kelajakdagi foydaga nisbati AKTX|Kelajakdagi narxning foydaga nisbati Enlivex Therapeutics Ltd. ENLV|Q32 Bio Inc - Kelajakdagi narxning foydaga nisbati|GeoVax Labs, Inc. - Forvard P/E multiplikatori|EDSA: Kelajakdagi narxning foydaga nisbati|iBio (IBIO) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati CARM (Carisma Therapeutics Inc.)|BOLT (Bolt Biotherapeutics Inc.) - Forvard P/E multiplikatori|HCWB: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori APVO|Forvard P/E multiplikatori AIM ImmunoTech, Inc. (AIM)|Kelajakdagi narxning foydaga nisbati Aditxt, Inc. ADTX|Kelajakdagi narx-foyda multiplikatori GRI|XRTX - Kelajakdagi narxning foydaga nisbati|Vyome Therapeutics (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|indaptusrx.com (INDP) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati SCNI|CALI: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori AFMD|Kapitalizatsiyaning prognoz qilingan foydaga nisbati allakos.com|Kelajakdagi narxning foydaga nisbati HOOKIPA Pharma HOOK|IGMS - Prognoz qilingan narxning foydaga nisbati|ITOS - Kelajakdagi narxning foydaga nisbati|Ocean Biomedical Inc (OCEA) - Prognoz qilingan narxning foydaga nisbati|TCBP (TC BioPharm (Holdings) PLC) - Prognoz qilingan narxning foydaga nisbati|Third Harmonic Bio Inc (THRD) - Forvard P/E multiplikatori
